We are live on ! Find out more
BG

Bellevue Group Portfolio holdings

AUM $4.2B
1-Year Est. Return 54.85%
This Fund
S&P 500
This Quarter Est. Return
-6.91%
1 Year Est. Return
+54.85%
3 Year Est. Return
+140.3%
5 Year Est. Return
+171.01%
10 Year Est. Return
+915.55%
AUM
$488M
AUM Growth
-$65.2M
Cap. Flow
-$17.8M
Cap. Flow %
-3.65%
Top 10 Hldgs %
32.78%
Holding
126
New
4
Increased
19
Reduced
35
Closed
4

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$5.8M
2
INCY icon
Incyte
INCY
+$5.8M
3
BCR
CR Bard Inc.
BCR
+$5.67M
4
AKRX
Akorn Inc
AKRX
+$4.79M
5
EW icon
Edwards Lifesciences
EW
+$3.89M

Top Sells

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$6.82M
2
ILMN icon
Illumina
ILMN
+$5.64M
3
AMSG
Amsurg Corp
AMSG
+$4.79M
4
SYK icon
Stryker
SYK
+$2.92M
5
CI icon
Cigna
CI
+$2.88M

Sector Composition

Rank Sector Weight
1 Healthcare 91.87%
2 Financials 0.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GWPH
101
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$670K 0.14%
6,000
– –
DVA icon
102
DaVita
DVA
$15.2B
$642K 0.13%
10,000
– –
NVRO
103
DELISTED
NEVRO CORP.
NVRO
$632K 0.13%
8,700
+1,200
+16% +$103K
VAR
104
DELISTED
Varian Medical Systems, Inc.
VAR
$628K 0.13%
7,983
– –
KITE
105
DELISTED
Kite Pharma, Inc.
KITE
$628K 0.13%
14,000
– –
CLDX icon
106
Celldex Therapeutics
CLDX
$2.77B
$566K 0.12%
10,667
– –
PODD icon
107
Insulet
PODD
$11.4B
$565K 0.12%
15,000
– –
LFWD icon
108
ReWalk Robotics
LFWD
$22.3M
$560K 0.11%
+95
New +$726K
QTNT
109
DELISTED
Quotient Limited Ordinary Shares
QTNT
$532K 0.11%
2,750
– –
ESPR
110
DELISTED
Esperion Therapeutics
ESPR
$501K 0.1%
40,000
– –
RMD icon
111
ResMed
RMD
$28.9B
$496K 0.1%
8,000
– –
TBPH icon
112
Theravance Biopharma
TBPH
$877M
$492K 0.1%
15,428
-3,000
-16% -$93.1K
NVAX icon
113
Novavax
NVAX
$1.35B
$410K 0.08%
16,250
– –
HZNP
114
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$388K 0.08%
24,000
-93,000
-79% -$1.69M
WBMD
115
DELISTED
WebMD Health Corp.
WBMD
$367K 0.08%
7,400
– –
HIND
116
Vyome Holdings
HIND
$15.1M
– –
0
– –
AAC
117
DELISTED
AAC Holdings
AAC
$326K 0.07%
45,000
– –
PEN icon
118
Penumbra
PEN
$12.5B
$319K 0.07%
5,000
– –
SGRY icon
119
Surgery Partners
SGRY
$2.09B
$238K 0.05%
15,000
– –
MYGN icon
120
Myriad Genetics
MYGN
$584M
$233K 0.05%
14,000
– –
WMGI
121
DELISTED
Wright Medical Group Inc
WMGI
$230K 0.05%
10,000
-60,309
-86% -$1.4M
EIGR
122
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$39K 0.01%
111
– –
QHC
123
DELISTED
Quorum Health Corporation
QHC
– –
-12,500
Closed -$78K
IPXL
124
DELISTED
Impax Laboratories, Inc.
IPXL
– –
-95,000
Closed -$2.25M
TMH
125
DELISTED
Team Health Holdings Inc
TMH
– –
-25,000
Closed -$814K
2 3 4
5
6

Similar funds

WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $4.22B AUM 21.28% 1-Year Est. Return
HIP
HUB Investment Partners Austin, Texas $4.18B AUM 24.76% 1-Year Est. Return
DT
DV Trading Chicago, Illinois $4.22B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.23B AUM 20.9% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.17B AUM 28.5% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $4.24B AUM 66.03% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

Bellevue Group's Q4 2016 Portfolio in Review

As of Q4 2016, Bellevue Group held 126 positions worth $488M, down 12% from $553M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Bellevue Group withdrew a net $17.8M in Q4 2016, closing 4 positions and reducing 35 holdings. Its most notable exit was Amsurg Corp, an estimated $4.79M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, down from 92% a quarter earlier, followed by Financials.

Against the trend, Bellevue Group opened a new position in Danaher worth $5.76M.

  • Bellevue Group's largest Q4 2016 buy was Danaher: 83,472 shares worth $5.76M.
  • Bellevue Group added most to Incyte in Q4 2016, an estimated $5.8M increase.
  • Bellevue Group's biggest Q4 2016 reduction was Cardinal Health, cutting an estimated $6.82M.
  • Bellevue Group fully exited Amsurg Corp in Q4 2016, selling an estimated $4.79M.
  • Bellevue Group's ten largest holdings make up 33% of its $488M portfolio in Q4 2016.
  • Bellevue Group opened 4 new positions and closed 4 in Q4 2016.
  • Bellevue Group's portfolio value fell 12% quarter-over-quarter to $488M.

Based on Bellevue Group's 13F filing for Q4 2016, filed 10 Feb 2017.